-
1
-
-
84878799611
-
Predicting functional effect of human missense mutations using PolyPhen-2
-
(Chapter 7:Unit7.20)
-
[1] Adzhubei, I., Jordan, D.M., Sunyaev, S.R., Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet., 2013 (Chapter 7:Unit7.20).
-
(2013)
Curr Protoc Hum Genet.
-
-
Adzhubei, I.1
Jordan, D.M.2
Sunyaev, S.R.3
-
2
-
-
84938913296
-
Genetics and genomic medicine in Saudi Arabia
-
[2] Alkuraya, F.S., Genetics and genomic medicine in Saudi Arabia. Mol Genet Genomic Med 2 (2014), 369–378.
-
(2014)
Mol Genet Genomic Med
, vol.2
, pp. 369-378
-
-
Alkuraya, F.S.1
-
3
-
-
84863775364
-
5-Oxoprolinase deficiency: report of the first human OPLAH mutation
-
[3] Almaghlouth, I.A., Mohamed, J.Y., Al-Amoudi, M., Al-Ahaidib, L., Al-Odaib, A., Alkuraya, F.S., 5-Oxoprolinase deficiency: report of the first human OPLAH mutation. Clin. Genet. 82 (2012), 193–196.
-
(2012)
Clin. Genet.
, vol.82
, pp. 193-196
-
-
Almaghlouth, I.A.1
Mohamed, J.Y.2
Al-Amoudi, M.3
Al-Ahaidib, L.4
Al-Odaib, A.5
Alkuraya, F.S.6
-
4
-
-
84990947952
-
Heterozygous Monocarboxylate Transporter 1 (MCT1, SLC16A1) Deficiency as a Cause of Recurrent Ketoacidosis
-
JIMD Rep. (Nov 26. [Epub ahead of print PubMed PMID: 26608392)
-
[4] Balasubramaniam, S., Lewis, B., Greed, L., Meili, D., Flier, A., Yamamoto, R., Bilić, K., Till, C., JO, S., Heterozygous Monocarboxylate Transporter 1 (MCT1, SLC16A1) Deficiency as a Cause of Recurrent Ketoacidosis. JIMD Rep. 2015 (Nov 26. [Epub ahead of print PubMed PMID: 26608392).
-
(2015)
-
-
Balasubramaniam, S.1
Lewis, B.2
Greed, L.3
Meili, D.4
Flier, A.5
Yamamoto, R.6
Bilić, K.7
Till, C.8
JO, S.9
-
5
-
-
84942748557
-
Disorders of glutathione and γ-glutamyl cycle
-
N. Blau M. Duran K.M. Gibson C. Dionisi-Vici Springer-Verlag Berlin Heidelberg
-
[5] Blau, N., Dionisi-Vici, C., Disorders of glutathione and γ-glutamyl cycle. Blau, N., Duran, M., Gibson, K.M., Dionisi-Vici, C., (eds.) Physician's Guide to the Diagnosis, Treatment, and Follow-up of Inherited Metabolic Diseases, 2014, Springer-Verlag, Berlin Heidelberg, 661–669.
-
(2014)
Physician's Guide to the Diagnosis, Treatment, and Follow-up of Inherited Metabolic Diseases
, pp. 661-669
-
-
Blau, N.1
Dionisi-Vici, C.2
-
6
-
-
77649113698
-
The lure of treatment: expanded newborn screening and the curious case of histidinemia
-
[6] Brosco, J.P., Sanders, L.M., Dharia, R., Guez, G., Feudtner, C., The lure of treatment: expanded newborn screening and the curious case of histidinemia. Pediatrics 125 (2010), 417–419.
-
(2010)
Pediatrics
, vol.125
, pp. 417-419
-
-
Brosco, J.P.1
Sanders, L.M.2
Dharia, R.3
Guez, G.4
Feudtner, C.5
-
7
-
-
84902977671
-
5-oxoprolinuria in heterozygous patients for 5-oxoprolinase (OPLAH) missense changes
-
JIMD Rep.
-
[7] Calpena, E., Casado, M., Martínez-Rubio, D., Nascimento, A., Colomer, J., Gargallo, E., García-Cazorla, A., Palau, F., Artuch, R., Espinós, C., 5-oxoprolinuria in heterozygous patients for 5-oxoprolinase (OPLAH) missense changes. JIMD Rep., 7, 2013, 123–128.
-
(2013)
, vol.7
, pp. 123-128
-
-
Calpena, E.1
Casado, M.2
Martínez-Rubio, D.3
Nascimento, A.4
Colomer, J.5
Gargallo, E.6
García-Cazorla, A.7
Palau, F.8
Artuch, R.9
Espinós, C.10
-
8
-
-
84939889954
-
New insights into the genetics of 5-oxoprolinase deficiency and further evidence that it is a benign biochemical condition
-
[8] Calpena, E., Deshpande, A.A., Yap, S., Kumar, A., Manning, N.J., Bachhawat, A.K., Espinós, C., New insights into the genetics of 5-oxoprolinase deficiency and further evidence that it is a benign biochemical condition. Eur. J. Pediatr. 174 (2015), 407–411.
-
(2015)
Eur. J. Pediatr.
, vol.174
, pp. 407-411
-
-
Calpena, E.1
Deshpande, A.A.2
Yap, S.3
Kumar, A.4
Manning, N.J.5
Bachhawat, A.K.6
Espinós, C.7
-
9
-
-
84862777146
-
Predicting the effects of frameshifting indels
-
[9] Hu, J., Ng, P.C., Predicting the effects of frameshifting indels. Genome Biol., 13, 2012, R9.
-
(2012)
Genome Biol.
, vol.13
, pp. R9
-
-
Hu, J.1
Ng, P.C.2
-
10
-
-
84864826447
-
Pyroglutamic acid: throwing light on a lightlystudied metabolite
-
[10] Kumar, A., Bachhawat, A.K., Pyroglutamic acid: throwing light on a lightlystudied metabolite. Curr Sci 102 (2012), 288–297.
-
(2012)
Curr Sci
, vol.102
, pp. 288-297
-
-
Kumar, A.1
Bachhawat, A.K.2
-
11
-
-
68149165614
-
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm
-
[11] Kumar, P., Henikoff, S., Ng, P.C., Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4 (2009), 1073–1081.
-
(2009)
Nat. Protoc.
, vol.4
, pp. 1073-1081
-
-
Kumar, P.1
Henikoff, S.2
Ng, P.C.3
-
12
-
-
84941992690
-
Five Chinese patients with5-oxoprolinuria due to glutathione synthetase and 5-oxoprolinase deficiencies
-
[12] Li, X., Ding, Y., Liu, Y., Ma, Y., Song, J., Wang, Q., Yang, Y., Five Chinese patients with5-oxoprolinuria due to glutathione synthetase and 5-oxoprolinase deficiencies. Brain Dev. 37 (2015), 952–959.
-
(2015)
Brain Dev.
, vol.37
, pp. 952-959
-
-
Li, X.1
Ding, Y.2
Liu, Y.3
Ma, Y.4
Song, J.5
Wang, Q.6
Yang, Y.7
-
13
-
-
84939444869
-
Disorders in the metabolism of glutathione and imidazole dipeptides
-
J.-M. Saudubray G. van den Berghe J.H. Walter Springer-Verlag Berlin Heidelberg
-
[13] Mayatepek, E., Jaeken, E., Disorders in the metabolism of glutathione and imidazole dipeptides. Saudubray, J.-M., van den Berghe, G., Walter, J.H., (eds.) Inborn Metabolic Diseases, 2012, Springer-Verlag, Berlin Heidelberg, 423–430.
-
(2012)
Inborn Metabolic Diseases
, pp. 423-430
-
-
Mayatepek, E.1
Jaeken, E.2
-
14
-
-
24344452154
-
Glutathione synthetase deficiency
-
[14] Njålsson, R., Glutathione synthetase deficiency. Cell. Mol. Life Sci. 62 (2005), 1938–1945.
-
(2005)
Cell. Mol. Life Sci.
, vol.62
, pp. 1938-1945
-
-
Njålsson, R.1
-
15
-
-
74949092081
-
Detection of nonneutral substitution rates on mammalian phylogenies
-
[15] Pollard, K.S., Hubisz, M.J., Rosenbloom, K.R., Siepel, A., Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 20 (2010), 110–121.
-
(2010)
Genome Res.
, vol.20
, pp. 110-121
-
-
Pollard, K.S.1
Hubisz, M.J.2
Rosenbloom, K.R.3
Siepel, A.4
-
16
-
-
84922031814
-
Functional characterizationof 5-oxoproline transport via SLC16A1/MCT1
-
[16] Sasaki, S., Futagi, Y., Kobayashi, M., Ogura, J., Iseki, K., Functional characterizationof 5-oxoproline transport via SLC16A1/MCT1. J Biol Chem. 290 (2015), 2303–2311.
-
(2015)
J Biol Chem.
, vol.290
, pp. 2303-2311
-
-
Sasaki, S.1
Futagi, Y.2
Kobayashi, M.3
Ogura, J.4
Iseki, K.5
-
17
-
-
84938676853
-
Consanguinity and rare mutations outside of MCCC genes underlie nonspecific phenotypes of MCCD
-
[17] Shepard, P.J., Barshop, B.A., Baumgartner, M.R., Hansen, J.B., Jepsen, K., Smith, E.N., Frazer, K.A., Consanguinity and rare mutations outside of MCCC genes underlie nonspecific phenotypes of MCCD. Genet Med 17 (2015), 660–667.
-
(2015)
Genet Med
, vol.17
, pp. 660-667
-
-
Shepard, P.J.1
Barshop, B.A.2
Baumgartner, M.R.3
Hansen, J.B.4
Jepsen, K.5
Smith, E.N.6
Frazer, K.A.7
-
18
-
-
84910107272
-
Monocarboxylate transporter 1 deficiency and ketone utilization
-
[18] van Hasselt, P.M., Ferdinandusse, S., Monroe, G.R., Ruiter, J.P., Turkenburg, M., Geerlings, M.J., Duran, K., Harakalova, M., van der Zwaag, B., Monavari, A.A., Okur, I., Sharrard, M.J., Cleary, M., O'Connell, N., Walker, V., Rubio-Gozalbo, M.E., de Vries, M.C., Visser, G., Houwen, R.H., van der Smagt, J.J., Verhoeven-Duif, N.M., Wanders, R.J., van Haaften, G., Monocarboxylate transporter 1 deficiency and ketone utilization. N. Engl. J. Med. 371 (2014), 1900–1907.
-
(2014)
N. Engl. J. Med.
, vol.371
, pp. 1900-1907
-
-
van Hasselt, P.M.1
Ferdinandusse, S.2
Monroe, G.R.3
Ruiter, J.P.4
Turkenburg, M.5
Geerlings, M.J.6
Duran, K.7
Harakalova, M.8
van der Zwaag, B.9
Monavari, A.A.10
Okur, I.11
Sharrard, M.J.12
Cleary, M.13
O'Connell, N.14
Walker, V.15
Rubio-Gozalbo, M.E.16
de Vries, M.C.17
Visser, G.18
Houwen, R.H.19
van der Smagt, J.J.20
Verhoeven-Duif, N.M.21
Wanders, R.J.22
van Haaften, G.23
more..
-
19
-
-
84962953721
-
Exome sequencing and the management of neurometabolicdisorders
-
[19] Tarailo-Graovac, M., Shyr, C., Ross, C.J., Horvath, G.A., Salvarinova, R., Ye, X.C., Zhang, L.H., Bhavsar, A.P., Lee, J.J., Drögemöller, B.I., Abdelsayed, M., Alfadhel, M., Armstrong, L., Baumgartner, M.R., Burda, P., Connolly, M.B., Cameron, J., Demos, M., Dewan, T., Dionne, J., Evans, A.M., Friedman, J.M., Garber, I., Lewis, S., Ling, J., Mandal, R., Mattman, A., McKinnon, M., Michoulas, A., Metzger, D., Ogunbayo, O.A., Rakic, B., Rozmus, J., Ruben, P., Sayson, B., Santra, S., Schultz, K.R., Selby, K., Shekel, P., Sirrs, S., Skrypnyk, C., Superti-Furga, A., Turvey, S.E., Van Allen, M.I., Wishart, D., Wu, J., Zafeiriou, D., Kluijtmans, L., Wevers, R.A., Eydoux, P., Lehman, A.M., Vallance, H., Stockler-Ipsiroglu, S., Sinclair, G., Wasserman, W.W., van Karnebeek, C.D., Exome sequencing and the management of neurometabolicdisorders. N. Engl. J. Med. 374 (2016), 2246–2255.
-
(2016)
N. Engl. J. Med.
, vol.374
, pp. 2246-2255
-
-
Tarailo-Graovac, M.1
Shyr, C.2
Ross, C.J.3
Horvath, G.A.4
Salvarinova, R.5
Ye, X.C.6
Zhang, L.H.7
Bhavsar, A.P.8
Lee, J.J.9
Drögemöller, B.I.10
Abdelsayed, M.11
Alfadhel, M.12
Armstrong, L.13
Baumgartner, M.R.14
Burda, P.15
Connolly, M.B.16
Cameron, J.17
Demos, M.18
Dewan, T.19
Dionne, J.20
Evans, A.M.21
Friedman, J.M.22
Garber, I.23
Lewis, S.24
Ling, J.25
Mandal, R.26
Mattman, A.27
McKinnon, M.28
Michoulas, A.29
Metzger, D.30
Ogunbayo, O.A.31
Rakic, B.32
Rozmus, J.33
Ruben, P.34
Sayson, B.35
Santra, S.36
Schultz, K.R.37
Selby, K.38
Shekel, P.39
Sirrs, S.40
Skrypnyk, C.41
Superti-Furga, A.42
Turvey, S.E.43
Van Allen, M.I.44
Wishart, D.45
Wu, J.46
Zafeiriou, D.47
Kluijtmans, L.48
Wevers, R.A.49
Eydoux, P.50
Lehman, A.M.51
Vallance, H.52
Stockler-Ipsiroglu, S.53
Sinclair, G.54
Wasserman, W.W.55
van Karnebeek, C.D.56
more..
-
20
-
-
0142107437
-
Redox state of glutathione and thioredoxin in differentiation and apoptosis
-
[20] Watson, W.H., Chen, Y., Jones, D.P., Redox state of glutathione and thioredoxin in differentiation and apoptosis. Biofactors 17 (2003), 307–314.
-
(2003)
Biofactors
, vol.17
, pp. 307-314
-
-
Watson, W.H.1
Chen, Y.2
Jones, D.P.3
-
21
-
-
77957241766
-
3-Methylglutaconic aciduria type I redefined: a syndrome with late-onset leukoencephalopathy
-
[21] Wortmann, S.B., Kremer, B.H., Graham, A., Willemsen, M.A., Loupatty, F.J., Hogg, S.L., Engelke, U.F., Kluijtmans, L.A., Wanders, R.J., Illsinger, S., Wilcken, B., Cruysberg, J.R., Das, A.M., Morava, E., Wevers, R.A., 3-Methylglutaconic aciduria type I redefined: a syndrome with late-onset leukoencephalopathy. Neurology 75 (2010), 1079–1083.
-
(2010)
Neurology
, vol.75
, pp. 1079-1083
-
-
Wortmann, S.B.1
Kremer, B.H.2
Graham, A.3
Willemsen, M.A.4
Loupatty, F.J.5
Hogg, S.L.6
Engelke, U.F.7
Kluijtmans, L.A.8
Wanders, R.J.9
Illsinger, S.10
Wilcken, B.11
Cruysberg, J.R.12
Das, A.M.13
Morava, E.14
Wevers, R.A.15
|